基础化工：供给端扰动，关注草甘膦投资机会

Investment Rating - The industry investment rating is "Outperform the Market" (maintained) [2] Core Viewpoints - The report highlights potential investment opportunities in the glyphosate sector due to supply-side disruptions and the ongoing legal challenges faced by Bayer, which could reshape the industry landscape [5] - The report suggests that domestic companies in China are likely to benefit from the potential reduction in global glyphosate production if Bayer withdraws from high-risk operations [5] - There is significant price increase potential for glyphosate, with current prices at 23,300 CNY per ton, which is approximately 2.5 times lower than the historical peak price of 80,300 CNY per ton [5] Summary by Sections Market Performance - The report provides a comparative performance analysis showing a decline of 26% in the basic chemical sector against the CSI 300 index [3] Supply Chain Dynamics - Bayer's glyphosate production capacity is 370,000 tons per year, accounting for 31.4% of the global capacity, while the remaining 68.6% is concentrated in China [5] - The total number of glyphosate lawsuits against Bayer has increased to approximately 181,000, with 67,000 cases still awaiting resolution [5] Price Trends and Profitability - Glyphosate's weekly inventory as of May 23, 2025, was 60,300 tons, reflecting a decrease of 6,300 tons, indicating a trend towards inventory reduction [5] - The report notes that the gross profit margin for glyphosate is currently at a historical low, suggesting a potential for price recovery [5] Investment Recommendations - The report recommends focusing on companies such as Jiangshan Chemical, Xingfa Group, and Xin'an Chemical, which are well-positioned to benefit from the anticipated changes in the glyphosate market [5]